Thoracic aortic aneurysm future or investigational therapies

Jump to navigation Jump to search

Thoracic aortic aneurysm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thoracic Aortic Aneurysm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

General Approach to Imaging in Thoracic Aortic Aneurysm

Chest X Ray

MRI

CT

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Endovascular Stent Grafting

Lifestyle Changes

Special Scenarios

Management during Pregnancy

Case Studies

Case #1

Thoracic aortic aneurysm future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thoracic aortic aneurysm future or investigational therapies

CDC on Thoracic aortic aneurysm future or investigational therapies

Thoracic aortic aneurysm future or investigational therapies in the news

Blogs on Thoracic aortic aneurysm future or investigational therapies

Directions to Hospitals Treating Thoracic aortic aneurysm future or investigational therapies

Risk calculators and risk factors for Thoracic aortic aneurysm future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Future or investigational therapies

Recent advances in thoracic aortic aneurysm treatment:

  • The use of endovascular stent grafting, which is a less invasive alternative to open surgery, for the treatment of descending thoracic and thoracoabdominal aneurysms.
  • Open-surgical versus endovascular stenting showed a decrease of operative mortality and a decrease in the occurrence of paraplegia, blood loss, length of ICU stay, and operative time with endovascular stenting.
  • Even though late survival rates are equivalent between open surgical repair and endovascular repair, the early operative mortality rates of endovascular repair are lower
  • The advances in aortic substitutes, cerebral protection, and perioperative care have led to improved results

References

Template:WH Template:WS